April 23, 2026 Antisense Oligonucleotides Reverse Rare Neurodevelopmental Disorder in Preclinical Models
March 23, 2026 Oral Semaglutide Fails to Slow Alzheimer’s Decline in Phase 3 Trials | News-Medical.net